文献速递免疫规划

莱姆病螺旋体OspA蛋白中可诱导杀菌抗体应答的线性表位鉴定:对疫苗开发的启示

Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development.
PubMed 文献 · Vaccine · 2017-05-04

研究鉴定了莱姆病螺旋体OspA蛋白第221-240位氨基酸的线性表位(OspA221-240),该表位不含疑似诱发自身免疫的区域。小鼠中该肽段具免疫原性,所诱导抗体可表面标记伯氏疏螺旋体并显示补体依赖性杀菌活性。作者假设将该表位整合入基于OspC的多价嵌合表位疫苗抗原可能通过协同机制预防莱姆病。

要点

  • OspA221-240线性表位不含与LFA-1相似、疑似诱发自身免疫的OspA区域。
  • OspA221-240肽段在小鼠中具免疫原性,诱导的抗体具补体依赖性杀菌活性。
  • BLAST分析发现OspA221-240存在多种变体及OspB中密切相关序列。

核心结论

  • OspA221-240线性表位可诱导针对伯氏疏螺旋体的杀菌抗体应答,且不含疑似诱发自身免疫的区域。
  • 作者假设将该表位整合入基于OspC的多价嵌合表位疫苗抗原,可能通过协同机制产生预防莱姆病的亚单位疫苗。

研究设计与样本

  • 基础研究:鉴定OspA线性表位,并在小鼠中评价肽段免疫原性及抗体功能。

主要发现

  • OspA221-240肽段免疫小鼠后产生的抗体在免疫荧光试验中可表面标记伯氏疏螺旋体,并显示强效抗体介导的补体依赖性杀菌活性。
  • BLAST分析鉴定出OspA221-240的多种变体以及OspB中一段密切相关的序列。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The lipoprotein OspA is produced by the Lyme disease spirochetes primarily in unfed ticks. OspA production is down-regulated by the blood meal and it is not produced in mammals except for possible transient production during late stage infection in patients with Lyme arthritis. Vaccination with OspA elicits antibody (Ab) that can target spirochetes in the tick midgut during feeding and inhibit transmission to mammals. OspA was the primary component of the human LYMErix™ vaccine. LYMErix™ was available from 1998 to 2002 but then pulled from the market due to declining sales as a result of unsubstantiated concerns about vaccination induced adverse events and poor efficacy. It was postulated that a segment of OspA that shares sequence similarity with a region in human LFA-1 and may trigger putative autoimmune events. While evidence supporting such a link has not been demonstrated, most efforts to move forward with OspA as a vaccine component have sought to eliminate this region of concern. Here we identify an OspA linear epitope localized within OspA amino acid residues 221-240 (OspA221-240) that lacks the OspA region suggested to elicit autoimmunity. A peptide consisting of residues 221-240 was immunogenic in mice. Ab raised against OspA221-240 peptide surface labeled B. burgdorferi in IFAs and displayed potent Ab mediated-complement dependent bactericidal activity. BLAST analyses identified several variants of OspA221-240 and a closely related sequence in OspB. It is our hypothesis that integration of the OspA221-240 epitope into a multivalent-OspC based chimeric epitope based vaccine antigen (chimeritope) could result in a subunit vaccine that protects against Lyme disease through synergistic mechanisms.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Izac JR, Oliver LD, Earnhart CG, et al. Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development. Vaccine. 2017. PMID: 28479174. doi:10.1016/j.vaccine.2017.04.079

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。